World News – UA – Muscular Dystrophy Association Awards Five Grants Totaling Over $ 1.6 Million For Amyotrophic Lateral Sclerosis (ALS) Research


MDA continues to step up the fight against ALS during this difficult time, building on its $ 168 million research commitment

NEW YORK, Sep 30, 2020 / PRNewswire / – The Muscular Dystrophy Association (MDA) today announced five new MDA grants totaling more than $ 1.6 million for research focused on amyotrophic lateral sclerosis ( ALS), commonly known as “Lou Gehrig’s disease” “MDA has spent over $ 168 million on ALS research, including $ 20 million over the past decade

« We are in a time of unprecedented progress in ALS, in large part thanks to the foundation established by MDA Investments, » says Sharon Hesterlee, PhD, Director of Research at MDA « We now have a better understanding of the processes underlying this disease and the ability to target specific genes where genetic causes are identified « 

The newly funded projects will aim to: create a clinical trial platform to test multiple drugs simultaneously; deploy an ALS toolkit; continue to develop a biobank and database that can be used by ALS researchers; develop and validate a new gene therapy strategy for ALS and frontotemporal degeneration (FTD), and prepare for a personalized clinical trial of a new treatment for symptoms of ALS, while also investigating risk factors and cause of ALS

Due to COVID, MDA had to cancel its spring review session Funding for these projects was reviewed in 2019 For a full list of individual scholarships, visit MDA Grants at a Glance

For 70 years, the Muscular Dystrophy Association (MDA) has been committed to transforming the lives of people with muscular dystrophy, ALS and related neuromuscular diseases through scientific innovations and care As a primary source of funding neuromuscular disease research outside of the federal government, MDA has committed over $ 1 billion to accelerate the discovery of therapies and cures The research we have supported is directly linked to life-changing therapies Multiple Neuromuscular Diseases MDA’s MOVR is the first and only data center that consolidates clinical, genetic, and patient-reported data for multiple neuromuscular diseases to improve health outcomes and accelerate drug development MDA supports the largest network of multidisciplinary clinics, offering the best care in its category in more than 150 d The best medical facilities in the country Our resource center offers personalized specialist support and we offer lectures, events and materials for families and healthcare providers During COVID-19, MDA continues to produce virtual events and programs to support our community For more information visit mdaorg


World News – UA – The Muscular Dystrophy Association Awards Five Grants Totaling Over $ 1.6 Million For Amyotrophic Lateral Sclerosis (ALS) Research



Donnez votre point de vue et aboonez-vous!



Votre point de vue compte, donnez votre avis

[maxbutton id= »1″]